ALBERT

All Library Books, journals and Electronic Records Telegrafenberg

feed icon rss

Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
  • 1
    Digitale Medien
    Digitale Medien
    New York, N.Y. : Wiley-Blackwell
    Journal of Cellular Biochemistry 50 (1992), S. 128-131 
    ISSN: 0730-2312
    Schlagwort(e): bladder carcinoma ; chemoprevention ; chemotherapy ; Life and Medical Sciences ; Cell & Developmental Biology
    Quelle: Wiley InterScience Backfile Collection 1832-2000
    Thema: Biologie , Chemie und Pharmazie , Medizin
    Notizen: α-Interferon combined with 5-fluorouracil results in significant antitumoral activity im metastatic bladder carcinoma refractory to standard MVAC chemotherapy.As a single agent, α-interferon is ineffective for invasive ormetastatic diseasem, but appears to contribute to the increased response rate of patients with invasive chemotherapy-refractory disease. Although most patinets with superficial bladder carcinoma will not develop invasive disease, patients in complete remission from invasive disease are at high risk for relapse.In vitro assays indicate that fenretinide (4-HPR) line, α-interferon, and 5-fluorouracil posses significant antitumoral activity in human transitional cell carcinoma (TCC) lines. Some features of postchemotherapy-refractory TCC are similar to those of initial superficial disease (senhsitivity to biological therapy). The biological study of patients with residual postchemotherapy disease may permit the development of strategies which will prevent the recurrence of malignancy within the bladder following an initial complete remission, in addition to developin strategies forthe selection and treatment of patients with high risk superficial disease. © 1992 Wiley-Liss, Inc.
    Zusätzliches Material: 1 Ill.
    Materialart: Digitale Medien
    Standort Signatur Erwartet Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie hier...